News
The company released three new products today that are available today for preorder on Fitbit’s website and will be sold worldwide in late September.
The consumer genomics company's existing offering, called AncestryHealth, sold clinician-ordered tests that were not cleared or approved by the FDA.
Also IntelyCare makes slew of new hires and PixCell Medical adds to board chair.
Castor, a cloud-based clinical data platform designed to automate the research process, announced recently it closed a $12 million Series A funding round.
The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.
The app will facilitate the exchange of crucial information such as X-rays and guidance to ensure orthopaedic injuries get treatment in an appropriate time frame.
The device was originally developed at MIT with Harvard Medical School.
During a HIMSS20 Digital session, Trapollo CEO Mike Braham described some of the ways that remote care apps can support patient needs.
Digital Diagnostics, formerly IDx, is looking to expand into the skin health space with this new purchase.
Also: Klara closes $15 million for digital patient engagement; Trellus Health collects $5 million seed funding and announces exclusive commercialization deal.